Series C funding round for Alladapt Immunotherapeutics raising $60M in February 2020
Series C funding round for Alladapt Immunotherapeutics raising $60M in February 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Julie McDermott |
| Angel | Georges Harik |
| Angel | Jeremy Yap |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$180M
Top Valuation
-
Alladapt Immunotherapeutics raised $60M in a Series C round.
The round was announced on 02/01/20.